Christopher M. Frederick

ORCID: 0000-0002-8979-1616
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • SARS-CoV-2 and COVID-19 Research

Regenstrief Institute
2023

Background Real-world performance of COVID-19 diagnostic tests under Emergency Use Authorization (EUA) must be assessed. We describe overall trends in the serology context real-world implementation. Methods Six health systems estimated odds seropositivity and positive percent agreement (PPA) test among people with confirmed SARS-CoV-2 infection by molecular test. In each dataset, we present ratio PPA, key clinical, demographic, practice parameters. Results A total 15,615 were observed to...

10.1371/journal.pone.0279956 article EN cc-by PLoS ONE 2023-02-03
Coming Soon ...